Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens

Abstract

AbstractBackgroundPredicting whether a patient's platelet refractoriness (PR) is due to immune or nonimmune causes can be challenging. This study compared the demographics and clinical history of PR patients with human leukocyte antigen (HLA) antibodies (HLA‐PR) versus PR patients without HLA antibodies.Materials and MethodsA retrospective review of all patients with PR consults at a single institution over a 3‐year period was performed. Patient charts were reviewed for all patients with confirmed PR, and demographic information (e.g., sex, race and ethnicity, preferred language) and clinical history (e.g., pregnancy, transfusion, primary diagnosis) were collected. Patient characteristics were compared among the HLA and non‐HLA cohorts.ResultsA total of 295 patients with confirmed PR were identified, of whom approximately 70% did not have HLA antibodies and 30% did. Approximately 84% of the HLA‐PR cohort was female. A history of transfusions was not associated with HLA‐PR (p = .1). A history of pregnancy was strongly associated with the occurrence of HLA‐PR (p < .001). Splenomegaly was associated with PR in the absence of HLA alloimmunization whereas infection, fever, bleeding, and disseminated intravascular coagulation were not.ConclusionIn this single‐institution retrospective review, a history of pregnancy was strongly associated with HLA‐PR, whereas a history of transfusion was not.